1[1]Shryock JC, Belardinelli L. Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology[J]. Am J Cardiol, 1997,79(12A):2-10.
2[2]Iskandrian AE, Heo J.Myocardial Perfusion Imaging During Adenosine-Induced Coronary Hyperemia[J]. Am J Cardiol, 1997,79(12A): 20-24.
3[3]O'Keefe JH Jr, Bateman TM, Handlin LR, et al. Four- versus 6-minute infusion protocol for adenosine-thallium-201 single photon emission computed tomography imaging[J]. Am Heart J,1995,129(3): 482-487.
4[4]Watanabe K, Sekiya M, Ikeda S, et al. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy[J]. J Nucl Med,1997,38(4): 577-581.
5[5]Pennell DJ, Mavrogeni S, Anagnostopoulos C, et al. Thallium myocardial perfusion tomography using intravenous dipyridamole combined with maximal dynamic exercise[J]. Nucl Med Commun,1993,14(11): 939-945.
6[6]Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality[J]. J Nucl Cardiol,2000,7(5): 439-446.
7[7]Ranhosky A, Kempthorne-Rawson J, the Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging[J]. Circulation,1990,81(4): 1205-1209.
8[8]Cerqueira MD, Verani MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the adenoscan multicenter trial registry[J]. J Am Coll Cardiol,1994,23(2):384-389.
